Advertisement

International Urology and Nephrology

, Volume 9, Issue 4, pp 347–352 | Cite as

Extrarenal effects of furosemide on distribution of salt and water

An indirect mechanism of the drug's action?
  • J. Prandota
Article

Abstract

The relatively scanty literature on the extrarenal effect of furosemide upon the distribution of salt and water in the body is reviewed. The collected data seem to indicate that corticosteroids participate in the natriuretic mechanism of this drug's action.

Keywords

Public Health Corticosteroid Furosemide Extrarenal Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ahmad, S.: Renal insensitivity to furosemide caused by chronic anticonvulsant therapy.Brit. med. J., 3, 657 (1974).Google Scholar
  2. 2.
    Brooks, S. M., Werk, E. E., Ackerman, S. J., Sullivan, J., Thrasher, K.: Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma.New Engl. J. Med., 286, 1125 (1972).Google Scholar
  3. 3.
    Brunner, H., Horster, F. A., Kuschinsky, G.: Die Beeinflussung eines experimentellen Stauungsödems der Ratte durch Chlorothiazid, Hydrocortison, Dexamethason, DOCA und Vasopressin.Arch. exp. Path. Pharmakol., 239, 359 (1960).Google Scholar
  4. 4.
    Burstyn, P. G., Horrobin, D. F., Manku, M. S.: Saluretic action of aldosterone in the presence of increased salt intake and restoration of normal action by prolactin or by oxytocin.J. Endocr., 55, 369 (1972).Google Scholar
  5. 5.
    Calesnick, B., Christensen, J. A., Richter, M.: Absorption and excretion of furosemide-S35 in human subjects.Proc. Soc. Exp. Biol. Med., 123, 17 (1966).Google Scholar
  6. 6.
    Clarkson, E. M.: General evidence for the natriuretic hormone. Proc. 5th Int. Congr. Nephrol., Mexico 1972 (Villarreal, H., ed.). S. Karger, Basel 1974, Vol. 2, p. 146.Google Scholar
  7. 7.
    Conney, A. H.: Drug metabolism and therapeutics.New Engl. J. Med., 280, 653 (1969).Google Scholar
  8. 8.
    Cuther, R. E., Forrey, A. W., Christopher, T. G., Kimpel, B. M.: Pharmacokinetics of furosemide in normal subjects and functionally anephric patients.Clin. Pharmacol. Ther., 15, 588 (1974).Google Scholar
  9. 9.
    De Luca, R., Spampinato, N., Triggiani, E., Del Giudice, E.: Sull' azione extrarenale della furosemide.Boll. Soc. ital. Biol. sper., 93, 262 (1967).Google Scholar
  10. 10.
    Dikshit, K., Vyden, J. K., Forrester, J. S., Chatterjee, K., Prakash, R., Swan, H. J. C.: Renal and extrarenal haemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.New Engl. J. Med., 288, 1087 (1973).Google Scholar
  11. 11.
    Documenta Geigy. Scientific Tables, 7th ed., Diem, K., Lenther, C., Geigy Pharmaceuticals Division of Ciba-Geigy Corp., Ardsley, New York 1974, pp. 428 and 743–750.Google Scholar
  12. 12.
    Formanek, K.: Die Wirkung von Saluretica auf experimentell erzeugte Ödeme der Rattenpfote.Med. Pharmacol. Exp., 13, 353 (1965).Google Scholar
  13. 13.
    Fraser, R., James, V. H. T., Brown, J. J., Isaac, P., Lever, A. F., Robertson, J. I. S.: Effect of angiotensin and of furosemide on plasma aldosterone, corticosterone, cortisol and renin in man.Lancet, 2, 989 (1965).Google Scholar
  14. 14.
    Goth, A.: Medical Pharmacology, 6th ed. Mosby Co., Saint Louis 1972, pp. 408 and 453.Google Scholar
  15. 15.
    Hahn, T. J., Birge, S. J., Scharp, C. R., Avioli, L. V.: Phenobarbital induced alterations in vitamin D metabolism.J. clin. Invest., 51, 741 (1972).Google Scholar
  16. 16.
    Hahn, T. J., Hendin, B. A., Scharp, C. R., Haddad, J. G.: Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.New Engl. J. Med., 287, 900 (1972).Google Scholar
  17. 17.
    Heidorn, G. H., Shemm, F. R.: The clinical use of corticotropin (ACTH) and adrenal corticosteroids in therapy of intractable edema.Amer. J. Med. Sci., 631, 229 (1955).Google Scholar
  18. 18.
    Horrobin, D. F., Manku, M. S., Burstyn, P. G.: Saluretic action of aldosterone in the presence of excess cortisol. Restoration of salt-retaining action by prolactin.J. Endocr., 56, 343 (1973).Google Scholar
  19. 19.
    Horrobin, D. F., Manku, M. S., Robertshaw, D.: Water-losing action of antidiuretic hormone in the presence of cortisol. Restoration of normal function by prolactin or by oxytocin.J. Endocr., 58, 135 (1973).Google Scholar
  20. 20.
    Horster, u. F. A., Kuschinsky, G., Peters, G., Brunner, H.: Der Einfluß einer venösen Stauung im Kopfbereich auf die Wasser- und Elektrolytausscheidung von Ratten.Arch. exp. Path. Pharmakol., 239, 345 (1960).Google Scholar
  21. 21.
    Jubiz, W., Meikle, A. W., Levinson, R. A., Mizutani, S., West, C. D., Tyler, F. H.: Effect of diphenylhydantoin on the metabolism of dexamethasone. Mechanism of the abnormal dexamethasone suppression in humans.New Engl. J. Med., 283, 11 (1970).Google Scholar
  22. 22.
    Kidner, P. H., Crosbie, W. A.: Pulmonary extravascular water volumes following myocardial infarction.Scot. med. J., 19, 14 (1974).Google Scholar
  23. 23.
    Koesters, S., Lüllmann, H.: Über die Beeinflussung eines tierexperimentellen Stauungsödems durch Furosemid.Klin. Wschr., 44, 1403 (1966).Google Scholar
  24. 24.
    Korochkin, I. M., Vinogradov, I. V., Alexandrov, A. A., Oganov, R. G.: Influence of furosemide on urinary excretion of catecholamines.Kardiologiia, 13, 106 (1973).Google Scholar
  25. 25.
    Levinsky, N. G.: A critical appraisal of some of the evidence for a natriuretic hormone. Proc. 5th Int. Congr. Nephrol., Mexico 1972 (Villarreal, H. ed.) S. Karger, Basel 1974, Vol. 2, pp. 162–166.Google Scholar
  26. 26.
    Linshaw, M. A., Gruskin, A. B.: Renal regulation of sodium.J. Pediat., 79, 325 (1971).Google Scholar
  27. 27.
    Lockett, M. F.: Actions of adrenal, hypophysial and renal hormones on the renal excretion of water and electrolytes. In: Progr. Biochem. Pharmacol., Vol. 7: Drugs Affecting Kidney Function and Metabolism (Edwards, K. D. G. ed.). S. Karger, Basel 1972, p. 102.Google Scholar
  28. 28.
    Prandota, J., Pruitt, A. W.: Furosemide. I. Binding to human albumin and plasma of nephrotic children. II. Pharmacokinetics, biliary excretion and metabolism in the rat. Abstracts of 5th Congress of Polish Pharmacological Society, Szczecin 1975.Google Scholar
  29. 29.
    Prandota, J., Witkowska, M.: Pharmacokinetics and metabolism of furosemide in man (submitted for publication).Google Scholar
  30. 30.
    Rosenthal, J., Boucher, R., Nowaczynski, W., Genest, J.: Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following furosemide administration.Canad. J. Physiol. Pharmacol., 46, 85 (1968).Google Scholar
  31. 31.
    Rupp, W.: Pharmacokinetics and pharmacodynamics of Lasix.Scot. med. J., 19, 5 (1974).Google Scholar
  32. 32.
    Sealey, J. E., Kirshman, J. D., Laragh, J. H.: Natriuretic activity in plasma and urine of salt-loaded man and sheep.J. clin. Invest., 48, 2210 (1969).Google Scholar
  33. 33.
    Senft, G.: Glucocorticoids as diuretic agents. In: Handbook of Experimental Pharmacology, Vol. 24. Springer-Verlag, Berlin 1969, pp. 550–565.Google Scholar
  34. 34.
    Smith, H. W.: Salt and water volume receptors.Amer. J. Med., 23, 623 (1957).Google Scholar
  35. 35.
    Soffer, L. J., Lesnicki, G., Sorkin, S. Z., Sobotka, H. H., Jacobs, M.: The utilization of intravenously injected salt in normals and in patients with Cushing's syndrome before and after administration of desoxycorticosterone acetate.J. clin. Invest., 23, 51 (1944).Google Scholar
  36. 36.
    Soffer, L. J., Dorfman, R. I., Gabrilove, J. L.: The Human Adrenal Gland. Kimpton, H., London 1961, pp. 138–152.Google Scholar
  37. 37.
    Tobian, L., Coffee, K., McCrea, P.: Evidence for a humoral factor of non-renal and non-adrenal origin which influences renal sodium excretion. Proc. 5th Int. Congr. Nephrol., Mexico 1972 (Villarreal, H. ed.). S. Karger, Basel 1974, Vol. 2, pp. 200–206.Google Scholar

Copyright information

© Akadémiai Kiadó 1977

Authors and Affiliations

  • J. Prandota
    • 1
  1. 1.Department of Pharmacology, Institute of Physiology and PharmacologyMedical AcademyWrocławPoland

Personalised recommendations